Bluebird bio completes spinout of oncology business 2seventy bio

The oncology unit is now its own, publicly traded company, called 2seventy bio, named for what CEO Nick Leschly contends is "the maximum speed of human thought."
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.